The trademark application AUREALIS THERAPEUTICS was filed by Aurealis Therapeutics AG, a corporation established under the laws of the Swiss Confederation (the "Applicant"). The application was published for oppositions on August 30, 2023, and it was registered by office on December 7, 2023 without any oppositions.
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 1 with Auxiliary preparations, carriers, and substances sold as integral components of pharmaceutical preparations.
The mark was filed in class 5 with following description of goods:
Pharmaceutical and veterinary preparations
Sanitary preparations for medical purposes
Dietetic food and substances adapted for medical or veterinary use
Dietary supplements for humans and animals
Health care products, namely, plasters, materials for dressings, ointments, sprays, injections, human therapeutics
Disinfectants
Preparations for destroying vermin
Fungicides, herbicides
Pharmaceuticals, biosimilars, medicine, drugs, especially immunomodulators and anticancer agents, such as antibodies, antibody fragments, checkpoint inhibitors and checkpoint modifiers, vaccines, especially anticancer vaccines, for human beings and animals
Prokaryotic organisms, especially genetically modified bacteria, in particular bacteria producing immunomodulators, anticancer agents, checkpoint inhibitors and checkpoint modifiers and vaccines, especially anticancer vaccines
Test kits and diagnostics, in particular manufactured using molecular biology, genetic engineering, immunological and biotechnological methods
Diagnostics relating to tumour precursors, benign and malignant tumours, autoimmune disorders and immunotherapy
Medicines for human purposes
Medicines for veterinary purposes
Bacteriological preparations for medical and veterinary use
Biological preparations for medical purposes
Biological preparations for veterinary purposes
Chemical preparations for medical purposes
Chemical preparations for pharmaceutical purposes
Chemical preparations for veterinary purposes
Pharmaceutical and veterinary preparations and substances in particular for the treatment of cancer, inflammatory diseases, immune system related diseases, especially autoimmune disorders, and other conditions which can be treated or ameliorated by antibodies or antibody fragments binding to, activating or blocking of a target antigen or ameliorated by immunomodulating factors
All the afore-mentioned goods not containing frankincense or components of frankincense.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto
Industrial analysis and research services
Scientific and technological services and research in the field of chemistry, biology, biotechnology, bio-pharmaceutics, molecular biology, bacteriology, immunology, veterinary and medical science, especially of immune system related diseases and of cancer
Research and development of diagnostics, diagnostic methods, pharmaceuticals, biosimilars, medicine, drugs, especially immunomodulating agents and anticancer agents, such as antibodies, antibody fragments, checkpoint inhibitors and modifiers, vaccines, especially anticancer vaccines, and prokaryotic organisms, such as genetically modified bacteria producing anticancer compounds, checkpoint inhibitors and checkpoint modifiers, vaccines, especially anticancer vaccines
Research and development for therapies, especially of immune system related disorders and cancer, using especially molecular biology, genetic engineering, immunological and biotechnological methods
Development of test procedures and test kits in the field of pharmaceuticals, biosimilars, medicine and drugs
Conducting scientific analyses
Medical research, laboratory services.
The mark was filed in class 44 with following description of goods:
Medical services
Veterinary services
Hygienic and beauty care for human beings or animals
Conducting medical and clinical analyses
Medical consultancy in connection with the treatment of individuals, in particular in the field of tumour precursors, benign and malignant tumours, autoimmune disorders and immunotherapy.